Lung Ultrasound in Assessment of Patients with COVID-19

• Main Author: Jianjian Liu, MD, Xin Ma, MD, Xujuan Pu, MD, Jingjing Huang, MD, Zongguo Yang, MD, Xia Shi, MD, Dou Wu, MD, Liping Sun, MD, Hui Zhang, MD
• Format: Article
• Language: English
• Published: Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2020-06-01
• Series: Advanced Ultrasound in Diagnosis and Therapy
• Subjects: |lung ultrasound|covid-19|novel coronavirus|pneumonia
• Online Access: http://www.journaladvancedultrasound.com:81/fileup/2576-2516/PDF/1587697092528-727333907.pdf
• ISSN: 2576-2516

Objective: To explore the diagnostic value of pulmonary ultrasound in patients with coronavirus disease 2019 (COVID-19).Methods: A total of 27 COVID-19 patients (mean age ± standard deviation, 62.6 ± 12.4 years) were enrolled in this study, including 14 males (51.9%) and 13 females (48.1%). Clinical information of these patients was collected, including age, gender, clinical manifestations, medical history, and laboratory indicators. All patients underwent ultrasound examination of their lungs and the results were analyzed.Results: Ultrasound examination of the lungs showed that the lesions in 24 patients were located in both lungs (88.9%), 1 patient's lesions were located in the left lung (3.7%), and 2 patients' lesions were located in the right lung (7.4%). Patients with abnormal lung changes mainly had consolidation, air bronchogram, pisces sign, comet-tail artifact, pleural effusion, fusion B-line, and either multiple or few B-lines.Conclusion: Pulmonary ultrasound examination was a convenient and radiation-free examination method, which could have important clinical value in evaluation of patients with COVID-19.